In an upbeat earnings report today (April 30), Anglo-Swedish drugmaker AstraZeneca reported $275 million in revenue from its Covid-19 vaccine in the first three months of the year.The vaccine, known as Vaxzevria, is one of four authorized for use against Covid-19 in the EU. It’s also been one of the more controversial ones: Many countries paused their rollout of the jab when it emerged that it can, in some rare cases, cause blood clots. AstraZeneca has also become embroiled in a public showdown with the EU over delayed supplies; the bloc is suing the company for alleged breach of contract. Meanwhile, the US has not approved the shot and plans to send most of its supply overseas.Excluding the
Hence then, the article about astrazeneca made 275 million from its covid vaccine this quarter was published today ( ) and is available onQuartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( AstraZeneca made $275 million from its Covid vaccine this quarter )